Small font size A Larger text size A Largest text size A

Travere Therapeutics Prices Upsized $475 Million Debt Offering

BY MT Newswires | CORPORATE | 05/07/26 05:25 AM EDT

05:25 AM EDT, 05/07/2026 (MT Newswires) -- Travere Therapeutics (TVTX) has priced a $475 million offering of 0.50% convertible senior unsecured notes due May 15, 2032, upsized from a previously planned $400 million, the company said late Wednesday.

Underwriters have a 30-day overallotment option to purchase up to an additional $50 million of the notes.

The company expects the offering to close Monday and plans to use part of the aggregate $460 million net proceeds to repurchase certain outstanding convertible notes, among other things.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

More Fixed Income News

China April exports rebound strongly, trade surplus widens ahead of Trump visit BY Reuters |ECONOMIC 03:27 AM EDT
China April exports rebound strongly, trade surplus widens ahead of Trump visit BY Reuters |ECONOMIC 03:25 AM EDT
China April exports rebound strongly after sluggish March, trade surplus widens BY Reuters |ECONOMIC 12:20 AM EDT
Job Reports Not Enough To Take USD-CAD Out Of Its Range Bound Environment, RBC says BY MT Newswires |ECONOMIC 05/08/26 04:28 PM EDT

All Fixed Income News

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.

fir_news_article